Angioplasty, Transluminal, Percutaneous Coronary Completed Phase 3 Trials for Heparin (DB01109)

Back to Angioplasty, Transluminal, Percutaneous Coronary

Also known as: Percutaneous Transluminal Coronary Angioplasty / Percutaneous transluminal coronary angioplasty (procedure) / Percutaneous balloon angioplasty of coronary artery / Coronary angioplasty (procedure) / Coronary angioplasty / Angioplasty of coronary artery [Ambiguous] / Angioplasty of coronary artery / Repair of coronary artery NOS (procedure) / Repair of coronary artery (procedure)

Indication	Status	Phase
DBCOND0031428 (Angioplasty, Transluminal, Percutaneous Coronary)	Completed	3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00269880	A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.	Treatment	Abciximab (DB00054) Heparin (DB01109)
NCT00271401	A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab	Treatment	Heparin (DB01109)